Antagonist properties of the novel antipsychotic, S16924, at cloned, human serotonin 5-HT(2C) receptors: A parallel phosphatidylinositol and calcium accumulation comparison with clozapine and haloperidol

被引:0
作者
Cussac D. [1 ]
Newman-Tancredi A. [1 ]
Nicolas J.-P. [2 ]
Boutin J.A. [2 ]
Millan M.J. [1 ]
机构
[1] Institut de Recherches Servier, Psychopharmacology Department, F-78290 Croissy-sur-Seine, 125, Chemin de Ronde
[2] Institut de Recherches Servier, Molec. and Cell. Pharmacol. Dept., F-78290 Croissy-sur-Seine, 125, Chemin de Ronde
关键词
5-HT(2C) receptors; Antipsychotic; Clozapine; Haloperidol; Phosphatidylinositol; Phospholipase C; Schizophrenia;
D O I
10.1007/s002100000221
中图分类号
学科分类号
摘要
The novel benzopyranopyrrolidine and potential antipsychotic, S16924 ((+)-2-(1-[2-(2,3-dihydrobenzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl)-1- (4-fluoro-phenyl)-ethanone), displays marked affinity for serotonin (5- HT)(1A), 5-HT(2A) and dopamine D2 receptors. Herein, we show that it also possesses high affinity for the cloned, INI isoform of h5-HT(2C) receptors (pK(i)=8.28) stably expressed in CHO cells. Similarly, clozapine (8.04) was a potent ligand, whereas haloperidol (<6.0) showed low affinity. As demonstrated by fura2-detection, S16924 concentration-dependently abolished (pK(b)=7.93) the 5-HT-induced elevation in intracellular levels of Ca2+ ([Ca2+](i)) in a CHO cell line stably expressing the INI isoform of 5- HT(2C) receptors. Further, as determined by depletion of membrane-bound levels of pre-labelled [3H]phosphatidylinositols ([3H]PI), S16924 concentration-dependently, surmountably and competitively blocked the activation of phospholipase C by 5-HT. This action was expressed with a pA2 of 7.89 according to Schild analysis. Clozapine likewise inhibited 5-HT- induced alterations in [Ca2+](i) and [3H]PI levels with PK(b)s of 7.43 and 7.84, respectively, whereas haloperidol was inactive (<5.0 in each case). Applied alone, S16924, clozapine and haloperidol modified levels of neither [Ca2+](i) nor [3H]PI. In conclusion, in analogy to clozapine, and in contrast to haloperidol, S16924 behaves as a potent and competitive antagonist at h5-HT(2C) receptors, the blockade of which may contribute to its distinctive functional profile of activity.
引用
收藏
页码:549 / 554
页数:5
相关论文
共 57 条
[51]  
Svensson T.H., Mathe J.M., Andersson J.L., Nomikos G.G., Hildebrand B.L., Marcus M., Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: Role of 5-HT<sub>2</sub> receptor and α<sub>1</sub>-adrenoceptor antagonism, J Clin Psychopharmacol, 15, (1995)
[52]  
Tecott L.H., Sun L.M., Akana S.F., Strack A.M., Lowenstein D.H., Dallman M.F., Jullius D., Eating disorder and epilepsy in mice lacking 5-HT<sub>2C</sub> serotonin receptors, Nature, 374, pp. 542-546, (1995)
[53]  
Vickers S.P., Clifton P.G., Dourish C.T., Tecott L.H., Reduced satiating effect of d-fenfluramine in serotonin 5-HT<sub>2C</sub> receptor mutant mice, Psychopharmacology, 143, pp. 309-314, (1998)
[54]  
Wadenberg M.L., Serotoninergic mechanisms in neuroleptic-induced catalepsy in the rat, Neurosci Biobehav Rev, 20, pp. 325-339, (1996)
[55]  
Westphal R.S., Sanders-Bush E., Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonist and inverse agonists, Mol Pharmacol, 46, pp. 937-942, (1994)
[56]  
Wetterling T., Mussigbrodt H.E., Weight gain: Side effect of atypical neuroleptics?, J Clin Psychopharmacol, 19, pp. 316-321, (1999)
[57]  
Wolf W.A., Schutz L.J., The serotonin 5-HT<sub>2C</sub> receptor is a prominent serotonin receptor in basal ganglia: Evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis, J Neurochem, 69, pp. 1449-1458, (1997)